Cargando…
Anti-Trypanosomal Proteasome Inhibitors Cure Hemolymphatic and Meningoencephalic Murine Infection Models of African Trypanosomiasis
Current anti-trypanosomal therapies suffer from problems of longer treatment duration, toxicity and inadequate efficacy, hence there is a need for safer, more efficacious and ‘easy to use’ oral drugs. Previously, we reported the discovery of the triazolopyrimidine (TP) class as selective kinetoplast...
Autores principales: | Rao, Srinivasa P S, Lakshminarayana, Suresh B, Jiricek, Jan, Kaiser, Marcel, Ritchie, Ryan, Myburgh, Elmarie, Supek, Frantisek, Tuntland, Tove, Nagle, Advait, Molteni, Valentina, Mäser, Pascal, Mottram, Jeremy C, Barrett, Michael P, Diagana, Thierry T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157554/ https://www.ncbi.nlm.nih.gov/pubmed/32079320 http://dx.doi.org/10.3390/tropicalmed5010028 |
Ejemplares similares
-
Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
por: Saldivia, Manuel, et al.
Publicado: (2020) -
Discovery of
Novel Quinoline-Based Proteasome Inhibitors
for Human African Trypanosomiasis (HAT)
por: Koester, Dennis C., et al.
Publicado: (2022) -
In Vivo Imaging of Trypanosome-Brain Interactions and Development of a Rapid Screening Test for Drugs against CNS Stage Trypanosomiasis
por: Myburgh, Elmarie, et al.
Publicado: (2013) -
Recent
Developments in Drug Discovery for Leishmaniasis
and Human African Trypanosomiasis
por: Nagle, Advait S., et al.
Publicado: (2014) -
Diseases of the Cardiovascular and Hemolymphatic Systems
por: Cebra, Christopher, et al.
Publicado: (2014)